1. Axéll T,
Zain RB,
Siwamogstham P,
Tantiniran D,
Thampipit J. Prevalence of oral soft tissue lesions in out-patients at two Malaysian and Thai dental schools.
Community Dent Oral Epidemiol 1990; 18(2):95-9.
2. Bánóczy J,
Rigó O. Prevalence study of oral precancerous lesions within a complex screening system in Hungary.
Community Dent Oral Epidemiol 1991; 19(5):265-7.
3. Eisen D. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients.
J Am Acad Dermatol. 2002; 46(2): 207-14.
4. Greenburg MS, Glick M, Ship JA. Burket's oral medicine.11th ed. Hamilton: BC Decker Inc; 2008. p. 89-95.
5. Volz T,
Caroli U,
Lüdtke H,
Bräutigam M,
Kohler-Späth H,
Röcken M,
et al. Pimecrolimus cream 1% in erosive oral lichen planus--a prospective randomized double-blind vehicle-controlled study.
Br J Dermatol 2008; 159(4):936-41.
6. Silverman S Jr,
Gorsky M,
Lozada-Nur F. A prospective follow-up study of 570 patients with oral lichen planus: persistence, remission, and malignant association.
Oral Surg Oral Med Oral Pathol 1985; 60(1):30-4.
7. Shen ZY,
Liu W,
Zhu LK,
Feng JQ,
Tang GY,
Zhou ZT. A retrospective clinicopathological study on oral lichen planus and malignant transformation: analysis of 518 cases.
Med Oral Patol Oral Cir Bucal 2012;17(6):e943-7.
8. Radfar L, Wild RC, Suresh L. A comparative treatment study of topical tacrolimus and clobetasol in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105(2):187-93.
9. McCaughey C,
Machan M,
Bennett R,
Zone JJ,
Hull CM. Pimecrolimus 1% cream for oral erosive lichen planus: a 6-week randomized, double-blind, vehicle-controlled study with a 6-week open-label extension to assess efficacy and safety. J Eur Acad Dermatol Venereol 2011; 25(9):1061-7.
10. Lodi G,
Carrozzo M,
Furness S,
Thongprasom K. Interventions for treating oral lichen planus: a systematic review.
Br J Dermatol2012; 166(5): 938-47.
11. Azizi A,
Lawaf S. The comparison of efficacy of adcortyl ointment and topical tacrolimus in treatment of erosive oral lichen planus.
J Dent Res Dent Clin Dent Prospects 2007;1(3):99-102.
12. Ruzicka T,
Assmann T,
Homey B. Tacrolimus: the drug for the turn of the millennium?
Arch Dermatol 1999;135(5):574-80.
13. Laeijendecker R,
Tank B,
Dekker SK,
Neumann HA. A comparison of treatment of oral lichen planus with topical tacrolimus and triamcinolone acetonide ointment. Acta Derm Venereol 2006;86(3):227-9.
14. Shichinohe R,
Shibaki A,
Nishie W,
Tateishi Y,
Shimizu H. Successful treatment of severe recalcitrant erosive oral lichen planus with topical tacrolimus. J Eur Acad Dermatol Venereol 2006; 20(1): 66-8.
15. Thongprasom K,
Luangjarmekorn L,
Sererat T,
Taweesap W. Relative efficacy of fluocinolone acetonide compared with triamcinolone acetonide in treatment of oral lichen planus.
J Oral Pathol Med. 1992;21(10):456-8.
16. Scully C,
Eisen D,
Carrozzo M.Management of oral lichen planus.
Am J Clin Dermatol 2000; 1(5):287-306.
17. Becker JC,
Houben R,
Vetter CS,
Bröcker EB. The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case report.
BMC Cancer 2006; 6:7.
18. Mattsson U,
Magnusson B,
Jontell M. Squamous cell carcinoma in a patient with oral lichen planus treated with topical application of tacrolimus.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 110(1):e19-25.
19. Passeron T, Lacour JP, Fontas E, Ortonne JP. Treatment of oral erosive lichen planus with 1% pimecrolimus cream: a double-blind, randomized, prospective trial with measurement of pimecrolimus levels in the blood. Arch Dermatol 2007;143(4): 472-6.
20. Swift JC,
Rees TD,
Plemons JM,
Hallmon WW,
Wright JC. The effectiveness of 1% pimecrolimus cream in the treatment of oral erosive lichen planus.
J Periodontol 2005;76(4):627-35.
21. Gorouhi F, Solhpour A, Beitollahi JM, Afshar S, Davari P, Hashemi P, et al. Randomized trial of pimecrolimus cream versus triamcinolone acetonide paste in the treatment of oral lichen planus.
J Am Acad Dermatol 2007;57(5):806-13.
